Sirolimus as a primary immunosuppressant in calcineurin-inhibitor induced nephrotoxicity

被引：0
|
作者：
Kushwaha, SS [1 ]
Khalpey, Z [1 ]
Frantz, RP [1 ]
Rodeheffer, RJ [1 ]
Clavell, AL [1 ]
Edwards, BS [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2006年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：51A / 51A
页数：1
相关论文
共 50 条
  • [31] Use of Fenoldopam in the Treatment of Calcineurin Inhibitor Induced Nephrotoxicity
    Thompson, Melissa
    Gokun, Jane
    Clifford, Timothy
    Macaulay, Tracy
    CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [32] Genomic-Derived Markers for Early Detection of Calcineurin Inhibitor Immunosuppressant-Mediated Nephrotoxicity
    Cui, Yuxia
    Huang, Qihong
    Auman, James Todd
    Knight, Brian
    Jin, Xidong
    Blanchard, Kerry T.
    Chou, Jeff
    Jayadev, Supriya
    Paules, Richard S.
    TOXICOLOGICAL SCIENCES, 2011, 124 (01) : 23 - 34
  • [33] Calcineurin-inhibitor induced pain syndrome due to interaction with clarithromycin: A case report
    Inaba, Satoshi
    Okumura, Hisatoshi
    Aoki, Tatsuya
    Kawashima, Atsushi
    JOURNAL OF GENERAL AND FAMILY MEDICINE, 2025, 26 (02): : 166 - 168
  • [34] Conversion from calcineurin-inhibitor (CNI) based immunosuppression to Sirolimus in chronic CNI toxicity after renal transplantation
    Diekmann, F
    Waiser, J
    Einecke, G
    Dragun, D
    Fritsche, L
    Neumayer, HH
    Budde, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 364A - 364A
  • [35] Sirolimus-based, calcineurin-inhibitor sparing immunotherapy, long-term (6-year) results
    Conti, David J.
    Petrov, Roman
    Elbalhoul, Ossama
    Gallichio, Michael
    TRANSPLANT IMMUNOLOGY, 2008, 20 (1-2) : 12 - 13
  • [36] Mycophenolate Mofetil and Calcineurin-Inhibitor Reduction: Recent Progress
    Grinyo, Josep M.
    Cruzado, Josep M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (11) : 2447 - 2452
  • [37] Primer: histopathology of calcineurin-inhibitor toxicity in renal allografts
    Peter Liptak
    Bela Ivanyi
    Nature Clinical Practice Nephrology, 2006, 2 : 398 - 404
  • [38] Calcineurin-Inhibitor Minimization in Pediatric Heart Transplant Recipients
    Bock, M. J.
    Shankel, T.
    Fitts, J.
    Tan, R.
    Chinnock, R. E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S406 - S407
  • [39] Human Primary Renal Tubuloids as Tools for Calcineurin Inhibitor Nephrotoxicity Assessment
    Zheng, Bingxuan
    Tian, Puxun
    Dou, Meng
    Deng, Ge
    Ding, Chenguang
    Shi, Yuting
    Gao, Yang
    Zhang, Xingzhe
    TRANSPLANTATION, 2022, 106 (09) : S720 - S720
  • [40] Sirolimus allows calcineurin-inhibitor withdrawal in heart transplant patients with renal impairment resulting in improved renal function.
    Zolty, R
    Keller, KE
    Ireland, NP
    Frisk, RL
    Stepien, LD
    Lowes, BD
    Shakar, S
    Wolfel, EE
    Lindenfeld, J
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 173 - 173
12345